ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its appointment of Paul Lucas as its new independent chair following founder Ken Clement’s decision to step down from the position.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its appointment of Paul Lucas as its new independent chair following founder Ken Clement’s decision to step down from the position.
TSX Staff Notice on Marijuana Validates Canopy's Longstanding Market Strategy to Protect Investors by Conducting Business Only Where it is Federally Legal to Do So; Should Bring Clarity and Relief to Investors Seeking to Participate in Listed and Compliant Cannabis Companies
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), announced today additional pre-clinical results in the development of INM-405 for the treatment of pain.
Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its acquisition of a 51 percent stake in JAG, a Denver-based group.
PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August.
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, in addition to its newly-acquired marketing and publishing entity, PotSaver, made a successful showing at last week’s Southwest Cannabis Conference and Expo in Phoenix, Arizona.
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
Just months before California is poised to legalize recreational marijuana, fatal wildfires tearing through three northern counties have scorched an untold number of cannabis farms.
InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) CEO Eric Adams recently sat down for two separate interviews regarding InMed's proprietary biosynthesis process, their patent filings and their research on using cannabinoids to treat various diseases.
Plus, the cannabis infused products manufacturer, is pleased to announce the closing of its Series A financing. The Financing was comprised of $2 Million USD of Series A Preferred Stock (the “Shares”), and was led by The Green Opportunity Funds.
Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) announceS that it has entered an exclusive strategic alliance with the corporate owner of a national chain of convenience stores to develop and implement cannabis distribution and retail sale opportunities at all Convenience Store Group locations.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids
These 5 Biotechs including InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) have a combined market cap of over $4 Billion. What should investors know about future growth for these companies?
Aurora Cannabis Inc. has agreed to a one-time special accommodation for the benefit of its underwriters due to very significant demand for the Bought Deal, to proceed with a concurrent, non-commissioned, non-brokered private placement of up to 2,000,000 units of the Company (the "Units") at a price of $3.00 per Unit (the "Offering").
Algae Dynamics Corp. (OTCQB: ADYNF) sees opportunity and greater market share in a soon to be legalized marijuana industry in Canada.